Matthew E. Burow

Affiliations: 
Biomedical Sciences Tulane University, New Orleans, LA, United States 
Area:
Cell Biology, Molecular Biology
Google:
"Matthew Burow"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lagarde CB, Kavalakatt J, Benz MC, et al. (2024) Obesity-associated epigenetic alterations and the obesity-breast cancer axis. Oncogene
Hossain F, Ucar DA, Monticone G, et al. (2023) Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer. Frontiers in Immunology. 14: 1244159
Dong S, Matossian MD, Yousefi H, et al. (2023) Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy. Scientific Reports. 13: 11843
Mukherjee D, Previs RA, Haines C, et al. (2023) Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis. Cancer Research
Mukherjee D, Previs RA, Haines CN, et al. (2023) Ca /Calmodulin Dependent Protein Kinase Kinase-2 (CaMKK2) promotes Protein Kinase G (PKG)-dependent actin cytoskeletal assembly to increase tumor metastasis. Biorxiv : the Preprint Server For Biology
Patel JR, Banjara B, Ohemeng A, et al. (2023) Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1. Nutrients. 15
Nguyen K, McConnell E, Edwards O, et al. (2022) GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies. Cancer Drug Resistance (Alhambra, Calif.). 5: 721-726
Bunnell BA, Martin EC, Matossian MD, et al. (2022) The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer. Cancer Metastasis Reviews
Dong S, Yousefi H, Savage IV, et al. (2022) Ceritinib is a novel triple negative breast cancer therapeutic agent. Molecular Cancer. 21: 138
King CT, Matossian MD, Savoie JJ, et al. (2022) Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer. Frontiers in Molecular Biosciences. 9: 847505
See more...